Indianapolis, March 10, 2025 - In a groundbreaking move for cancer care, Longevity Life Advisors has officially launched CancerEDGE, an innovative program set to transform the landscape of cancer genomics and precision health services. This program is designed to offer affordable and comprehensive access to advanced genomic testing and tailored health services, aiming to fill the gaps often left by standard insurance coverage.

As an exclusive offering for Wellabe policyholders, CancerEDGE membership is available for less than $30 per month, providing an incredible opportunity for individuals seeking to evaluate and manage their cancer risk with expert support.

What's Inside CancerEDGE?

CancerEDGE delivers a suite of features specifically tailored for Wellabe members, including:

Personalized Cancer Guidance: Members receive detailed resources to help understand and manage their unique cancer risks effectively.

Onsite Nurse Navigators: Trained professionals offer invaluable support, assisting patients in navigating complex diagnosis and treatment plans.

Access to Clinical Trials: Members gain opportunities to participate in cutting-edge research studies aimed at improving cancer treatment outcomes.

Genomic Testing: Advanced genomic assessments are conducted to evaluate cancer risks and inform personalized treatment strategies.

Dr. Paul R. Billings, Chief Medical Officer of Longevity Life, emphasized the importance of the CancerEDGE initiative, stating, “CancerEDGE empowers Wellabe policyholders to reliably assess their cancer risk and provides critical resources and support when needed. This program is designed to make valuable cancer services more accessible and affordable for everyone.”

Why is CancerEDGE So Critical?

Dismal statistics surrounding cancer highlight the urgent need for programs like CancerEDGE:

According to the British Journal of Cancer, one in two men and one in three women will face a cancer diagnosis in their lifetime.

Projections from the American Society of Clinical Oncology reveal that cancer is expected to become the leading cause of death in the U.S. by 2030.

Remarkably, cancer accounts for a significant portion of healthcare spending, underscoring the necessity for effective preventive measures and accessible treatment options.

About Longevity Life Advisors

Longevity Life Advisors combines leading expertise in insurance, technology, genomics, and healthcare to bridge the gap in cancer services. Their mission centers on empowering individuals with tools to understand genetic risks, promote preventative actions, and provide unwavering support throughout their healthcare journeys.

Join the Fight Against Cancer

With the launch of CancerEDGE, Longevity Life Advisors and Wellabe are not merely offering a service; they are creating a community dedicated to fighting cancer and safeguarding health, all while prioritizing affordability and accessibility.

For more information on how CancerEDGE can impact your life or the life of a loved one, visit CancerEDGE.com/wellabe. Together, we can revolutionize cancer care and pave the way for a healthier future!